Cite
An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells.
MLA
Tomasicchio, Michele, et al. “An Autologous Dendritic Cell Vaccine Polarizes a Th-1 Response Which Is Tumoricidal to Patient-Derived Breast Cancer Cells.” Cancer Immunology, Immunotherapy, vol. 68, no. 1, Jan. 2019, pp. 71–83. EBSCOhost, https://doi.org/10.1007/s00262-018-2238-5.
APA
Tomasicchio, M., Semple, L., Esmail, A., Meldau, R., Randall, P., Pooran, A., Davids, M., Cairncross, L., Anderson, D., Downs, J., Malherbe, F., Novitzky, N., Panieri, E., Oelofse, S., Londt, R., Naiker, T., & Dheda, K. (2019). An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells. Cancer Immunology, Immunotherapy, 68(1), 71–83. https://doi.org/10.1007/s00262-018-2238-5
Chicago
Tomasicchio, Michele, Lynn Semple, Aliasgar Esmail, Richard Meldau, Philippa Randall, Anil Pooran, Malika Davids, et al. 2019. “An Autologous Dendritic Cell Vaccine Polarizes a Th-1 Response Which Is Tumoricidal to Patient-Derived Breast Cancer Cells.” Cancer Immunology, Immunotherapy 68 (1): 71–83. doi:10.1007/s00262-018-2238-5.